Whistleblowers say drugmaker Mallinckrodt bribed doctors to increase sales. Exposing Misconduct.

Whistleblowers say drugmaker Mallinckrodt bribed doctors to increase sales

April 30, 2019

Two whistleblowers at a drugmaker that recently made news for a major price hike alleged the company bribed doctors to increase sales, according to CNN, citing court documents unveiled this week.

The whistleblowers accused Questcor Pharmaceuticals, now Mallinckrodt, of using a “multi-tiered strategy” to boost sales of the drug H.P. Acthar Gel, used to treat a rare infant seizure disorder. The drug’s price has spiked nearly 97,000 percent in the past two decades, from $40 per vial in 2000 to almost $39,000, according to CNN. Much of the increase occurred before Mallinckrodt acquired the company in 2014, though the price hikes have continued in the last five years.

Read more here.
The materials on this website are for general information purposes only and should not be construed as legal advice, legal opinion or any other advice on any specific facts or circumstances. Readers should not act or refrain from acting upon this information without seeking professional advice. Transmission of information on or by use of this website is not intended to create, and receipt does not constitute, a lawyer-client relationship between the sender and receiver.
Mobile Menu